Can tadalafil or fluoxetine cause blurred vision?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Tadalafil or Fluoxetine Cause Blurred Vision?

Yes, both tadalafil and fluoxetine can cause blurred vision, though through different mechanisms and with different frequencies.

Tadalafil and Visual Effects

Tadalafil is directly associated with visual disturbances as a recognized adverse effect. The FDA drug label explicitly lists blurred vision as a known side effect 1. The mechanism involves inhibition of phosphodiesterase type 6 in the retina, which can cause difficulty discriminating blue from green colors, bluish tones in vision, or difficulty seeing in dim light 2.

Specific Visual Risks with Tadalafil:

  • Common visual effects include blurred vision, changes in color vision (particularly blue/green discrimination), and visual disturbances occurring in less than 0.1% of patients across clinical trials 1
  • More serious complications have been reported postmarketing, including retinal vein occlusion, retinal artery occlusion, and visual field defects 1
  • Central serous chorioretinopathy (CSCR) has been documented in case reports, presenting with blurred vision, serous macular detachments, and increased choroidal thickness that resolved after discontinuing tadalafil 3, 4
  • Non-arteritic anterior ischemic optic neuropathy (NAION) has been rarely reported, potentially causing permanent vision loss, particularly in patients with anatomic risk factors like "crowded disc," age over 50, diabetes, or hypertension 1

The 2024 palliative care guidelines note that tadalafil may cause "more hypotension, headache, syncope, and visual disturbances" particularly in older adults 5.

Fluoxetine and Visual Effects

Fluoxetine is also associated with blurred vision, though the mechanism differs from tadalafil. Vision blurred is listed among typical SSRI side effects 6, and recent large-scale pharmacovigilance data confirms this association.

Specific Visual Risks with Fluoxetine:

  • Real-world data analysis from the FDA Adverse Event Reporting System identified fluoxetine as having a 45.9% rate of severe eye disorders among SSRIs—the highest in its class 7
  • Common visual symptoms include vision blurred/reduced visual acuity (63.7% of reports), night blindness, vitreous floaters, photophobia, diplopia, and visual field defects 8
  • Persistent effects: In 49 patients reporting visual problems with serotonin reuptake inhibitors, vision problems endured even after drug discontinuation 8
  • Impact on function: 74 patients indicated visual side effects were severe enough to affect daily activities, and 50 reported work impairment 8

A 2024 disproportionality analysis found fluoxetine significantly associated with vision blurred, visual impairment, and mydriasis, with most adverse events occurring within the first 30 days of treatment 7.

Clinical Implications

When evaluating blurred vision in patients taking either medication:

  1. Timing matters: Fluoxetine-related visual effects typically emerge within the first 30 days 7, while tadalafil effects can occur acutely with each dose
  2. Severity assessment: If vision loss is sudden or severe, consider NAION (tadalafil) or CSCR (tadalafil) and refer urgently to ophthalmology 1
  3. Reversibility: Tadalafil-related CSCR typically resolves within 3 months of discontinuation 3, but some fluoxetine-related visual problems may persist 8
  4. Risk stratification: For tadalafil, higher risk patients include those over 50, with diabetes, hypertension, or "crowded disc" anatomy 1

Both medications can definitively cause blurred vision, and prescribers should counsel patients about this risk at initiation and monitor for visual symptoms during treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.